Hemab Therapeutics Inc. Common Stock
COAG | NASDAQ
$41.38
+$0.96 (+2.38%)
At close: Oct 30, 2026, 3:59 PM ET
$41.66
+$0.28 (+0.68%)
After-hours:
Oct 30, 2026, 7:48 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
PE Ratio | -14.59 |
PEG Ratio | n/a |
PS Ratio | n/a |
PB Ratio | -5.28 |
P/FCF Ratio | -15.17 |
P/OCF Ratio | -15.18 |
OCF/S Ratio | n/a |
Debt / Equity Ratio | -0.01 |
Quick Ratio | 18.03 |
Current Ratio | 18.03 |
Asset Turnover | n/a |
Interest Coverage | n/a |
Return on Equity | 36.18% |
Return on Assets | -32.81% |
Return on Invested Capital | -37.82% |
Dividend Yield | n/a |
Payout Ratio | n/a |
FCF Payout Ratio | n/a |
Gross Profit Margin | n/a |
Net Profit Margin | n/a |
Pretax Profit Margin | n/a |
Operating Profit Margin | n/a |
FCF Margin | n/a |
EBITDA Margin | n/a |
Add to Watchlist
Select watchlists to add or remove COAG